Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
1982 • 1,317 citations
Treatment of the Malignant Carcinoid Syndrome
1986 • 852 citations
Metabolic Clearance and Plasma Half-Disappearance Time of Exogenous Somatostatin in Man*
1979 • 198 citations
Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic Cholera
1985 • 192 citations
Long-Term Treatment of a VIPoma With Somatostatin Analogue Resulting in Remission of Symptoms and Possible Shrinkage of Metastases
1985 • 188 citations
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
1985 • 157 citations
The Carcinoid Flush
1978 • 147 citations
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera
1982 • 104 citations
Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes
1986 • 96 citations
Treatment of the Malignant Carcinoid Syndrome
1987 • 75 citations
Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
1987 • 60 citations
Somatostatin Localization in Tissues
1986 • 44 citations
Somatostatin, gastrointestinal peptides, and the carcinoid syndrome.
1981 • 41 citations
Colorimetric assay of urinary 5-hydroxy-3-indoleacetic acid
1982 • 11 citations
Cited By (0)
No citing papers found in database